Background
==========

Obesity is recognised as a major cause of type 2 diabetes mellitus (T2DM) \[[@B1]-[@B4]\]. Changing lifestyles over the last decades have given rise to a global epidemic of overweight and obesity which has spread from developed to developing countries and from adults to children and adolescents \[[@B5]-[@B7]\]. In 2000, 15% of the Spain population were obese \[[@B8]\], and 9% suffered from T2DM \[[@B9]\]. If trends remain unchanged, conservative estimates are that 12% of the country population will be diabetic by 2030 \[[@B9]\]. The associated future burden of chronic diseases and health costs of the obesity epidemic are of serious concern.

Obesity is defined by the accumulation of excess body fat with potential harmful health effects \[[@B10]\]. A strong link between excess body weight and T2DM risk has long been established in the epidemiological literature. Further evidence showed that ectopic visceral fat accumulation, but not subcutaneous adipose tissue \[[@B11]\], largely accounted for the metabolic complications of obesity \[[@B12]\], such as abnormalities in glucose and lipid metabolism \[[@B13]\] and hepatic insulin resistance \[[@B13],[@B14]\], preceding the development of T2DM.

Anthropometry provides the universal basis for the clinical identification of obese people because the anthropometric methodology is easy to implement, inexpensive, and valid. Simple measures such as height, weight or waist and hip circumferences characterise overall and regional adiposity near as accurately as sophisticated reference methods \[[@B11]\]. The body mass index (BMI), which reflects body general adiposity, is valid for defining obesity at the population level but does not properly account for the wide variation in body fat distribution within individuals \[[@B10],[@B15]\]. BMI does not differentiate between fat and muscle mass \[[@B15]\], follows a non-linear association with body fat percent \[[@B16]\] and is poorly prognostic of obesity-related co-morbidities in subjects of short stature \[[@B17]\] or older age \[[@B18]\]. A proper characterisation of obesity-associated risk requieres that at least one indicator of visceral fat depots is measured. Waist measures such as waist circumference (WC) or waist-to-hip ratio (WHR) are stronger proxies for abdominal obesity than body mass index \[[@B11],[@B19]\]. Even for narrow ranges of BMI large differences in WC exist that account for sizeable variations in risk of chronic conditions such as diabetes or cardiovascular disease \[[@B12],[@B20]\], suggesting that indices of general and central adiposity provide complementary information. On an individual basis, there is discrepancy about which measure would better predict risk of T2DM as two previous meta-analyses found no clear differences for BMI, WC or WHR as predictors of diabetes \[[@B21],[@B22]\]. A further recent meta-analysis suggested that waist-to-height ratio (WHtR) would show a superior predictive ability than BMI or WC, although of limited clinical utility \[[@B23]\]. Using a combination of anthropometric measures to account for both the amount and distribution of body fat seems the best way of characterising obesity-associated T2DM risk \[[@B1],[@B2]\]. Body proportions related to height, such as the WHtR, relative height or leg length, cause further variations in BMI which are not associated with body fat percent \[[@B24],[@B25]\], and may provide additional insight into the association of obesity and T2DM \[[@B1],[@B26]-[@B28]\].

Given the aetiologic effect of excess body fat on T2DM and in order for preventive actions to be effective, the most accurate tools for the early identification of at-risk subjects must be adopted. No specific cut-offs exist yet for defining central obesity in Spanish population on the basis of WC and there is little prospective evidence in support of the appropriateness of applying American \[[@B29]\] or European \[[@B30]\] standards to the country population. The main objective of the present study was to obtain specific estimates of diabetes risk in Spain according to different anthropometric variables in a large cohort of participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain study, and to define those anthropometric values that would better predict future risk of T2DM in this population.

Methods
=======

Study sample
------------

The EPIC (European Prospective Investigation into Cancer and Nutrition) Study is an ongoing multi-centre prospective cohort study on diet, genetic and environmental factors and health. The study cohort involves over half a million participants from 10 European countries. The Spanish branch of EPIC comprises 41 438 participants mostly 30--65 years old at the time of enrolment (1992--1995). Participants were recruited mainly among blood donnors but also civil servants and general population from five Spanish regions, three in the North (Asturias, Gipuzkoa and Navarra) and two in the South (Granada and Murcia). Baseline data collection included the measure of anthropometric variables and questionnaire information on diet, lifestyles, medical history and drug consumption, as detailed elsewhere \[[@B31],[@B32]\].

All participants voluntarily agreed to take part in the study and gave informed consent. Ethical approval was granted by the Medical Ethical Committee of Bellvitge Hospital.

Assessment of anthropometric variables
--------------------------------------

Participants were invited to attend a physical examination in order to obtain relevant anthropometric information, according to standardised procedures. Height was registered by having the subjects barefoot and in upright position. With participants seated, sitting height was defined as the length from the seat to the top of the head, and leg length was computed as height minus sitting height. The sitting height ratio was then calculated as sitting-height divided by standing height. Weight was assessed with subjects in light underwear using a digital scale with a precision of 0.1 kg. Waist circumference was measured at the narrowest torso circumference for most participants, but the midpoint between the lower ribs and the iliac crest was used instead if the natural waist could not be identified. Finally, hip circumference was registered at the widest diameter of the buttocks. Height, and waist and hip circumferences were measured to the nearest 1 cm.

Body mass index was obtained as weight (in kg) divided by square height (in m). Waist-to-hip and waist-to-height ratios were computed as the quotient between waist and hip circumferences and between WC and height (in cm), respectively.

Full anthropometric data was available for 98.4% of participants.

Identification of incident diabetes cases
-----------------------------------------

A total of 2560 verified incident T2DM cases occurred between recruitment and December 31st, 2006 (mean follow-up time of 12.1 years). A sensitive approach was used for the ascertainment of T2DM cases based upon different sources of information including self-reported diabetes or consumption of diabetes medication during a follow-up interview 3 years after recruitment, hospital discharge databases, drug prescription records, and regional mortality registers and the National Death Index, for all centres, and record linkage with primary care registers for all centres except Granada (where access to primary care data was partly available for case verification, however). Furthermore, access to laboratory data on glycaemia and glycosilated hemoglobin (HbA~1c~) tests was available in Gipuzkoa.

Verification of possible T2DM cases was carried out by a team of trained health professionals by careful revision of clinical data and health information from all available sources. A definite case was defined if a physician diagnosis of type 2 diabetes was present in the medical history or otherwise evidence of diabetes from two independent sources (depending on study centre), according to the following criteria, 2-hour post-load glycaemia value ≥ 200 mg/dl after a 75-g oral glucose tolerance test (OGTT), HbA~1c~ \> 7%, fasting plasma glucose ≥ 126 mg/dl, non-fasting glycaemia ≥ 200 mg/dl, diabetes related medical visit (code E11.\_ of the 10th revision of the *International Classification of Diseases* (ICD-10)), self-report of diabetes, use of antidiabetic medication (A10 code of the World Health Organization Anatomical Therapeutic Chemical classification system \[[@B33]\]), or death certificate with ICD-10 code E11.

Incidence date was defined either as the earliest date of diagnosis or first antidiabetic drug use registered in the medical records, or the date of self-report. If only information on the month or year was available, the date of diabetes onset was defined at the middle of the corresponding period. For self-reported cases, when several self-reports were available, the incidence date was imputed at the midpoint between the date of the first positive report of diabetes by the participant and the previous negative self-report. Time at risk was calculated as the difference between age at T2DM diagnosis, death, or lost to follow-up, whichever occurred first, and age at recruitment. The ascertainment and verification process of T2DM cases followed the criteria and procedures defined in the EPIC-InterAct study. Further details can be found elsewhere \[[@B34]\].

Exclusions affected prevalent T2DM cases (n = 2383), participants with missing follow-up data on diabetes status (n = 713) and four non-type 2 diabetics. Participants with implausible anthropometric values (height \< 130 cm; BMI \< 16 kg/m^2^; WC \> 160 cm; or WC \< 60 cm and BMI \> 25 kg/m^2^) (n = 6), or missing data on anthropometry (n = 599) were further excluded. Finally, 14 019 men and 23 714 women completing 2513 incident cases of diabetes and near 457 000 person-years were available for analysis.

Covariate assessment
--------------------

Information on habitual diet of the previous year was gathered by means of a validated dietary history method during a personnal interview. Correction for mis-reporting of energy inake was applied by classifying participants as under-reporters, plausible reporters and over-reporters according to the predicted total energy expenditure (pTEE) method, as described by Méndez *et al.*\[[@B35]\]. A daily consumption of alcohol between 10--50 g in men and 5--25 g in women was regarded as 'moderate', with 'low' and 'high' consumption groups defined outside these ranges. Information was also collected on smoking status (never, former, current, unknown), educational level (primary school or lower, secondary or technical/professional school, university, unknown), and practice of recreational activities. Total MET-hours/week in walking, cycling and sports were computed to derive a four-category recreational physical activity index: inactive, moderately inactive, moderately active, active.

Statistical analyses
--------------------

Descriptive statistics by sex and diabetes status included median and interquartile range for continuous variables, and absolute and relative frequencies for categorical ones. Mann--Whitney U tests or *χ*^2^ test were applied to evaluate differences in the distribution of the data by diabetes status, as appropriate. Analyses were performed separately for men and women.

Hazard ratios of diabetes by sex-specific quartiles of anthropometric variables were computed for men and women separately taking the lowest quartile as the reference. Cox proportional hazards models were built with attained age as the time variable (entry time defined as age at recruitment and exit time defined as age at incident diabetes or age at censoring). Cox models were stratified by centre, age (in five-year categories), and follow-up time (\<5 years, 5--10 years, ≥10 years). The validity of the proportional hazards assumption was tested on the basis of Schoenfeld residuals. All analyses were controlled for total energy intake, plausibility of energy reporting, alcohol intake level, smoking status, educational attainment, recreational physical activity index, and menopausal status, in women. In order to analyse the independency of the reported associations, BMI models were further adjusted for WC, and central obesity models were adjusted for height and weight. Other covariates such as dietary (consumption of proteins, lipids, carbohydrates, red meat, processed meat, tea, coffee, fiber, and magnesium), or parity variables (in women), had no significant influence on risk estimates and were not included in the final models. Furthermore, several sensitivity analyses were conducted in order to test the robustness of results by excluding participants with short follow-up or chronic conditions at baseline, or by stratifying the results by categories of age, follow-up time and menopausal status.

The area under the receiver operating characteristic (ROC) curve was estimated for selected anthropometric variables and optimal cutoffs were defined at the maximum Youden index (J = sensitivity + specificity -- 1). Sensitivity and specificity values were also computed for WC at the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII) and International Diabetes Federation (IDF) cutoffs.

The 10-year cumulative incidence of diabetes was calculated according to NCEP-ATPIII waist categories, stratified by BMI (normal weight, overweight, obese), sex, and age group (40--49, 50--59, 60--69 years), as the cumulative number of cases at 10 years of follow-up divided by the total population in each stratum.

The population risk of diabetes attributable to excess body weight was calculated as *p*~*d*~*(RR - 1)/RR*; where *p*~*d*~ = prevalence of exposition among cases, and *RR* = multivariable-adjusted hazard ratio of diabetes in exposed *versus* non-exposed participants \[[@B36]\].

Non-linear associations of diabetes risk with BMI and WC were also modelled using restricted cubic splines with sex-specific distribution-based knots at the 5th, 25th, 50th, 75th and 95th percentiles of BMI and WC. Relative hazards of diabetes derived from adjusted Cox models were then plotted against continuous variables. Nelson-Aalen cumulative hazard estimates by BMI and WC categories were plotted separately for men and women.

Analyses were performed using STATA 10.1 (StataCorp LP, College Station, USA). All tests were two-sided and *P*-values \< 0.05 were considered significant.

Results
=======

As shown in Table [1](#T1){ref-type="table"}, the incidence of diabetes was higher in men than women, not showing clear geographical patterns. Cases were, in general, older, fatter, less educated, and less physically active (Table [2](#T2){ref-type="table"}). In addition, diabetic men were more prone to smoke, as opposed to diabetic women. Overall, differences in anthropometric variables between cases and non-cases were larger in women.

###### 

Incidence rates of diabetes in the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, by sex and center

              **Men**   **Women**                                               
  ---------- --------- ----------- ----- ---------------- -------- ------ ----- ----------------
    Total     170499      1278      750   605 (565--645)   290047   1252   432   407 (380--433)
   Asturias    35031       258      737   613 (512--714)   64689    266    411   399 (345--453)
   Gipuzkoa    45155       345      764   567 (507--628)   50635    195    385   355 (304--405)
   Navarra     43894       342      779   572 (511--634)   48810    239    490   433 (378--488)
   Granada     18572       99       533   421 (334--507)   62464    245    392   354 (310--399)
    Murcia     27847       234      840   725 (321--829)   63450    307    307   433 (378--488)

Rates per 100 000 person-years (with 95% confidence intervals) for the 30--64 age band.

^1^ Adjusted to the European Standard Population using the direct method.

###### 

Baseline general and anthropometrical characteristics of diabetic and non-diabetic members of the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, by sex

                                             **Men**   **Women**                                          
  ----------------------------------------- --------- ----------- ------- ------- ------- ------- ------- -------
                 Age (years)                  49.3       11.6      52.2    11.4    47.1    13.3    51.9    12.1
                 Height (cm)                  169.0       8.4      168.0    7.9    157.0    7.8    155.2    8.0
                 Weight (kg)                  80.0       13.4      84.5    15.4    66.8    13.8    76.4    16.8
          Waist circumference (cm)            98.0       11.0      103.5   12.0    85.0    15.0    97.0    14.0
           Hip circumference (cm)             104.0       7.7      106.6    9.0    104.0   11.0    111.0   14.0
             Sitting height (cm)              87.3        5.3      86.8     4.9    82.7     4.7    82.2     4.8
               Leg length (cm)                81.8        6.3      81.0     6.3    74.2     5.8    73.0     5.6
          Body mass index (kg/m^2^)           27.9        4.1      30.0     4.5    27.1     5.9    31.8     6.5
             Waist-to-hip ratio               0.94       0.06      0.97    0.06    0.82    0.08    0.86    0.07
            Waist-to-height ratio             0.58       0.07      0.62    0.07    0.54    0.10    0.63    0.09
                                              **N**      **%**     **N**   **%**   **N**   **%**   **N**   **%**
              BMI categories^1^                                                                               
                  Normal weight               1876       14.7       68      5.3    6637    29.5     63      5.1
                    Overweight                7572       59.4       569    44.7    9658    43.0     379    30.5
                        Obese                 3299       25.9       635    49.9    6178    27.5     799    64.4
              WC categories^2^                                                                                
                         Low                  3619       28.4       132    10.4    6582    29.3     48      3.9
                       Medium                 4813       37.8       409    32.2    6501    28.9     175    14.1
                         High                 4315       33.9       731    57.5    9390    41.8    1018    82.0
              Educational level                                                                               
                Primary or lower              7599       59.6       924    72.6    16524   73.5    1032    83.2
                     Secondary                2748       21.6       225    17.7    2631    11.7     62      5.0
                     University               2026       15.9       76      6.0    2260    10.1     26      2.1
                       Unknown                 374        2.9       47      3.7    1058     4.7     121     9.8
                   Smoking                                                                                    
                   Never smoker               3864       30.3       290    22.8    15699   69.9    1012    81.5
                  Former smoker               3861       30.3       360    28.3    2340    10.4     71      5.7
                       Smoker                 5016       39.4       620    48.7    4422    19.7     158    12.7
                      Unknown                   6         0.1        2      0.2     12      0.1      0       0
   Recreational physical activity index^3^                                                                    
                      Inactive                4353       34.1       472    37.1    8728    38.8     531    42.8
              Moderately inactive             3241       25.4       350    27.5    7447    33.1     387    31.2
                Moderately active             2765       21.7       258    20.3    4351    19.4     222    17.9
                        Active                2388       18.7       192    15.1    1947     8.7     101     8.1
              Menopausal status                                                                               
                  Pre-menopausal               \-                   \-             12530   55.8     449    36.2
                 Peri-menopausal               \-                   \-             2109     9.4     141    11.4
                 Post-menopausal               \-                   \-             7834    34.9     651    52.5

*BMI*: body mass index, *WC*: waist circumference.

All within-sex comparisons between cases and non-cases were significant at *P* \< 0.001 level, except for the recreational physical activity index (*P*~*men*~ = 0.003; *P*~*women*~ = 0.051).

^1^ Normal weight, BMI \< 25 kg/m^2^; overweight, 25 ≤ BMI \< 30 kg/m^2^; obese, BMI ≥ 30 kg/m^2^.

^2^ Low, WC \< 94 cm (men) or WC \< 80 cm (women); medium, 94 ≤ WC \< 102 cm (men) or 80 ≤ WC \< 88 cm (women); high, WC ≥ 102 cm (men) or WC ≥ 88 cm (women).

^3^ Sum of MET-h/week spent in walking, cycling and sports. Inactive, ≤19.50; moderately inactive, 19.51-33.75; moderately active, 33.76-54.75; active, \>54.75.

Table [3](#T3){ref-type="table"} shows the main results of the sex-specific analyses of diabetes risk by quartiles of anthropometric indices of general (BMI), gluteo-femoral (hip circumference), and central obesity (WC, WHR, or WHtR). The estimated risk of diabetes was generally higher for any level increase of body mass index or waist-related variables. Point estimates of T2DM risk (Q~4~*vs.* Q~1~) ranged from 1.5 for hip circumference to 2.6 for BMI, in men, and from 2.5 for hip circumference to 7.9 for WHtR, in women. Adjustment of BMI models for indices of central obesity did not affect the estimation of diabetes risk in men, but led to an attenuation of risk estimates in women. All variables remained independent predictors of T2DM risk in mutually adjusted models, except hip circumference.

###### 

Hazard ratio (HR) of diabetes by quartiles of anthropometrical indices in men and women from the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort

                           **Men**   **Women**                                                                                       
  ----------------------- --------- ----------- ------ ------------- ------ ------------- ------- ----- ------ -------------- ------ --------------
      Body mass index                                                                                                                       
            Q1              43152       135       1                    1                   73322   52     1                     1           
            Q2              43115       211      1.57   1.27 - 1.97   1.58   1.25 - 2.00   73311   132   1.51   1.08 - 2.11    1.26   0.90 - 1.77
            Q3              42155       343      2.02   1.63 - 2.50   2.07   1.64 - 2.61   71690   331   2.89   2.12 - 3.95    2.11   1.52 - 2.93
            Q4              40657       583      2.57   2.08 - 3.16   2.68   2.05 - 3.50   69564   726   4.14   3.04 - 5.64    2.48   1.73 - 3.57
    Waist circumference                                                                                                                     
            Q1              43948       118       1                    1                   79543   43     1                     1           
            Q2              42483       230      1.58   1.25 - 1.99   1.49   1.18 - 1.90   72348   137   2.19   1.52 - 3.14    2.02   1.40 - 2.91
            Q3              42502       353      1.92   1.54 - 2.40   1.74   1.37 - 2.22   69726   320   4.02   2.85 - 5.68    3.47   2.44 - 4.95
            Q4              40146       571      2.32   1.86 - 2.86   1.93   1.46 - 2.55   66272   741   5.93   4.21 - 8.36    4.57   3.12 - 6.68
     Hip circumference                                                                                                                      
            Q1              42690       197       1                    1                   75803   100    1                     1           
            Q2              44831       273      1.13   0.93 - 1.38   1.00   0.82 - 1.23   71293   192   1.56   1.21 - 2.02    1.24   0.96 - 1.61
            Q3              40094       317      1.49   1.23 - 1.80   1.21   0.98 - 1.49   74551   335   1.98   1.56 - 2.52    1.24   0.96 - 1.60
            Q4              41464       485      1.49   1.24 - 1.79   0.99   0.78 - 1.27   66241   614   2.50   1.97 - 3.17    1.00   0.73 - 1.35
    Waist-to-hip ratio                                                                                                                      
            Q1              49640       170       1                    1                   79106   80     1                     1           
            Q2              38989       226      1.28   1.04 - 1.57   1.17   0.95 - 1.45   77254   208   1.59   1.21 - 2.10    1.50   1.14 - 1.98
            Q3              47330       450      1.65   1.37 - 2.00   1.48   1.22 - 1.80   69546   337   2.27   1.74 - 2.97    1.98   1.52 - 2.60
            Q4              33121       426      1.63   1.34 - 1.99   1.30   1.05 - 1.60   61983   616   3.18   2.46 - 4.12    2.67   2.06 - 3.47
   Waist-to-height ratio                                                                                                                    
            Q1              43815       105       1                    1                   73889   30     1                     1           
            Q2              43545       224      1.53   1.20 - 1.96   1.48   1.15 - 1.89   73835   132   2.91   1.92 - 4.41    2.79   1.76 - 4.06
            Q3              41515       365      2.05   1.62 - 2.59   1.91   1.50 - 2.42   71746   314   5.00   3.34 - 7.49    4.54   2.79 - 6.40
            Q4              40204       578      2.32   1.84 - 2.93   2.07   1.60 - 2.69   68418   765   7.91   5.30 - 11.82   6.80   4.45 - 10.39

*Py*: person-years, *HR*: hazard ratio, *CI*: confidence interval.

^1^ Models stratified by centre, age, and follow-up time, and adjusted by total energy intake, plausibility of energy reporting, alcohol intake, smoking status, educational level and recreational physical activity.

^2^ Multivariable models mutually adjusted by height, weight, and waist and hip circumferences, as applicable. Covariates, total energy intake, plausibility of energy reporting, alcohol intake, smoking status, educational level, physical activity, and menopausal status (women). Models were stratified by centre, age, and follow-up time.

Cut-off points,

Body mass index (kg/m^2^), 26.12 (Q1-Q2), 28.10 (Q2-Q3), 30.34 (Q3-Q4) \[men\]; 24.64 (Q1-Q2), 27.37 (Q2-Q3), 30.74 (Q3-Q4) \[women\].

Waist circumference (cm), 93.0 (Q1-Q2), 98.8 (Q2-Q3), 104.5 (Q3-Q4) \[men\]; 79.0 (Q1-Q2), 86.0 (Q2-Q3), 94.0 (Q3-Q4) \[women\].

Hip circumference (cm), 100.5 (Q1-Q2), 104.5 (Q2-Q3), 108.8 (Q3-Q4) \[men\]; 99.0 (Q1-Q2), 104.5 (Q2-Q3), 111.0 (Q3-Q4) \[women\].

Waist-to-hip ratio, 0.91 (Q1-Q2), 0.94 (Q2-Q3), 0.98 (Q3-Q4) \[men\]; 0.78 (Q1-Q2), 0.82 (Q2-Q3), 0.86 (Q3-Q4) \[women\].

Waist-to-height ratio, 0.55 (Q1-Q2), 0.58 (Q2-Q3), 0.62 (Q3-Q4) \[men\]; 0.50 (Q1-Q2), 0.55 (Q2-Q3), 0.60 (Q3-Q4) \[women\].

The areas under the ROC curves for the principal anthropometric variables considered are shown in Table [4](#T4){ref-type="table"}. On an individual basis, WHtR revealed the highest area for both sexes, with optimal sensitivity/specificity cut-offs at 0.60 in men and 0.58 in women, as defined by the Youden's J statistic. Table [5](#T5){ref-type="table"} shows the comparison of discriminatory ability of several anthropometric cut-offs in regard to T2DM. Although more sensitive, the IDF criterion showed poorer specificity (\<30%), whereas the NCEP criterion resulted in more balanced sensitivity and specificity estimates and classified participants according to their diabetes status twice as good as the IDF values. In turn, a 0.5 WHtR threshold resulted in very poor specificity in this study.

###### 

Area under the curve (AUC) for different anthropometrical variables as predictors of incident diabetes in men and women from the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort

                                 **AUC**   **SE**    **95% CI**     **Optimal cutoff**^**1**^   **Sensitivity**   **Specificity**
  ----------------------------- --------- -------- --------------- --------------------------- ----------------- -----------------
  MEN                                                                                                                     
    Body mass index (kg/m^2^)     0.676    0.008    0.660 - 0.691             28.7                   66.7%             59.9%
    Waist circumference (cm)      0.672    0.008    0.657 - 0.687             99.4                   69.5%             55.8%
    Waist-to-hip ratio            0.646    0.008    0.631 - 0.661             0.95                   68.9%             53.2%
    Waist-to-height ratio         0.687    0.008    0.673 - 0.702             0.60                   66.1%             61.2%
  WOMEN                                                                                                                   
    Body mass index (kg/m^2^)     0.759    0.006    0.746 - 0.771             29.2                   71.8%             66.9%
    Waist circumference (cm)      0.773    0.006    0.760 - 0.785             90.4                   74.5%             67.6%
     Waist-to-hip ratio           0.722    0.007    0.708 - 0.735             0.84                   71.0%             61.9%
    Waist-to-height ratio         0.776    0.006    0.764 - 0.788             0.58                   76.6%             65.6%

*SE*: standard error, *CI*: confidence interval.

^1^ Maximum Youden index (J) value (J = sensitivity + specificity - 1).

###### 

Comparison of predefined anthropometric cut-offs for predicting incident diabetes in men and women from the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort

                                           **Sensitivity**   **Specificity**   **Correctly classified**^**1**^
  ---------------------------------------- ----------------- ----------------- ---------------------------------
  MEN                                                                           
  Body mass index ≥ 25 kg/m^2^             94.7%             14.7%             22.0%
  Body mass index ≥ 30 kg/m^2^             49.9%             74.1%             71.9%
  IDF waist circumference (WC ≥ 94 cm)     89.6%             28.4%             34.0%
  NCEP waist circumference (WC ≥ 102 cm)   57.5%             66.2%             65.4%
  Waist-to-hip ratio ≥ 0.90                94.4%             16.8%             23.8%
  Waist-to-height ratio ≥ 0.5              98.8%             4.8%              13.4%
  WOMEN                                                                         
  Body mass index ≥ 25 kg/m^2^             94.2%             29.5%             33.0%
  Body mass index ≥ 30 kg/m^2^             64.4%             72.5%             72.1%
  IDF waist circumference (WC ≥ 80 cm)     96.1%             29.3%             32.8%
  NCEP waist circumference (WC ≥ 88 cm)    82.0%             58.2%             59.5%
  Waist-to-hip ratio ≥ 0.85                64.4%             68.4%             68.2%
  Waist-to-height ratio ≥ 0.5              97.6%             26.3%             30.1%

*NCEP*: national cholesterol education program, *IDF*: international diabetes federation.

^1^ Proportion of participants with correctly classified diabetes status according to the respective cut-off point of each binary anthropometric variable considered.

In supplementary analyses, height, but not sitting-height ratio, was shown to be significantly associated with a decreased risk of T2DM both in men and women, regardless of total body weight or waist circumference (Additional file [1](#S1){ref-type="supplementary-material"}: Table S1). Predicted T2DM risk was consistently higher at incresing BMI WHO categories, and also independently in those with central obesity according to the NCEP-ATPIII criterion (Additional file [1](#S1){ref-type="supplementary-material"}: Table S2). Results did not change after further adjustment for dietary variables or exclusion of participants with chronic conditions at baseline (Additional file [1](#S1){ref-type="supplementary-material"}: Table S3). However, evidence of heterogeneity existed by follow-up strata, and by groups of age and menopausal status. The effect of a larger WC on T2DM risk was evaluated separately in normal weight, overweight and obese participants (Additional file [1](#S1){ref-type="supplementary-material"}: Table S4). Women presented higher risk estimates at high WC values, with obese participants of large WC (≥ 88 cm) showing up to 5.6-fold times higher risk of diabetes than their normal weight, low WC (\< 80 cm) counterparts (*versus* 2.8 times higher risk in men). Of note, less than 5% of women with normal WC became diabetic after 10 years of follow-up, even if obese and in the 60--69 years old group (Additional file [1](#S1){ref-type="supplementary-material"}: Table S5). Absolute risks were higher in men than women for any age, waist and BMI category. The population risk of diabetes attributable to excess body weight (BMI ≥ 25 kg/m^2^) in the EPIC-Spain cohort was estimated in 46% (95% CI, 33 - 59%) for men and 61% (95% CI, 52 - 71%) for women (Additional file [1](#S1){ref-type="supplementary-material"}: Table S6). If only obesity were targeted, the proportion of avoidable cases would reach an estimated 17% (95% CI, 13 - 21%) in men and 31% (95% CI, 27 - 36%) in women.

The modelling of T2DM risk related to the anthropometric indices evaluated using restricted cubic splines revealed a similar pattern for the studied indices within each sex, but appreciably different between sexes, showing curvilinear relationships with steeper slopes in women, while associations tended to reach a plateau at highest anthropometric values in men (Figure [1](#F1){ref-type="fig"}).

![**Relative risk of diabetes as a function of different anthropometric indices in men and women from the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort.** Restricted cubic splines modelling of T2DM risk according to variation in anthropometric variables, with knots at the 5th, 25th, 50th, 75th, and 95th percentiles. The reference (RR = 1, dashed line) was set at a body mass index equal to 25 kg/m^2^ (**A.1** and **B.1**), a waist circumference equal to 94 cm in men (**A.2**) or 80 cm in women (**B.2**), a waist-to-hip ratio equal to 0.90 in men (**A.3**) or 0.85 in women (**B.3**), and a waist-to-height ratio equal to 0.50 (**A.4** and **B.4**).](1472-6823-13-7-1){#F1}

Figure [2](#F2){ref-type="fig"} shows the cumulative hazard of diabetes by age for combined BMI and WC strata. Central obesity added independently to the risk of diabetes in each BMI category, but much more significantly in women, for whom the estimated cumulative hazard of diabetes in normal-waist participants remained below 15% even among the oldest.

![**Nelson-Aalen cumulative hazard estimates of diabetes by combined strata of body mass index and waist circumference in men (A) and women (B) from the Spanish EPIC (European Prospective Investigation into Cancer and Nutrition) cohort.** Body mass index strata (normal weight, overweight, obese) were defined according to WHO standard body mass index groups (\< 25, 25-29.99, ≥ 30 kg/m^2^); waist circumference strata were based on the presence of central obesity, defined by a waist circumference ≥ 102 cm in men or a waist circumference ≥ 88 cm in women.](1472-6823-13-7-2){#F2}

Discussion
==========

General and central obesity were both independent predictors of T2DM risk in this large prospective cohort of volunteers from different Spanish regions. Risk estimates at elevated values of BMI and WC were higher for women than for men. Also central obesity, although a moderate independent predictor of T2DM in men, showed the strongest association with diabetes in women. The measure of waist circumference in the clinical practice would thus be a valuable and inexpensive aid in the evaluation of diabetes risk, especially for women.

The practical need to distinguish between general and central obesity from an anthropometric perspective, raises the question about which indicator would be the best proxy for central obesity either in clinical and epidemiological settings. Literature showed that relative measures of WC, such as the waist-to-hip ratio, predicted risk of disease no better than WC alone \[[@B22]\], which guided the definition of central obesity to rely exclusively on WC \[[@B29],[@B30]\]. But recent findings have given support to the use of WHtR as a better central obesity index in the prediction of T2DM among different ethnic groups \[[@B26],[@B28],[@B37]-[@B39]\]. Height influences the shape and frame size of individuals, and the evidence suggests that taller people tend to be leaner (and meager) than their shorter counterparts \[[@B24]\]. In the present study, taller participants had around 25% reduced risk of becoming diabetic independently of their weight and abdominal perimeter. Since height is also conceived as a proxy indicator of childhood nutritional status, its strong association with diabetes may thus integrate a double dimension of actual physical characteristics and infancy socio-economic circumstances \[[@B40]\]. Our results supports waist-to-height ratio as the best single measure to predict risk of diabetes, presenting the largest area under the ROC curve in both sexes (AUC~men~ = 0.69; AUC~women~ = 0.78), in line with previous evidence, with an optimal cut-off value of 0.6, above the proposed threshold of 0.5 \[[@B37]\]. The consistency of the predictive ability of WHtR with regard to T2DM across different ethnic backgrounds, and sex groups, together with its simplicity, supports including this promising index systematically in future epidemiological studies in the field of diabetes and other chronic diseases \[[@B37],[@B41]\]. However, the definition of universal clinical thresholds (if at all possible) still warrants further investigation in different age groups and disease contexts. From a clinical point of view, although waist measures provide no dramatic gain in discriminatory ability as compared to BMI, given their independent and graded association with T2DM, the authors firmly believe that it deserves consideration the inclusion of central obesity measures (WC the simplest, WHtR the most discriminative) in clinical practice guidelines for the management of T2DM patients to assist diagnosis and decision-making by the physician, at least in the case of female patients. The combination of BMI and WC would allow a much more accurate ranking of individuals according to their disease risk. Our results show large differences in 10-year absolute risk of T2DM between normal-waist and high-waist female participants, further supporting the relevance of WC as a complementary measure for evaluating diabetes risk in women.

As a point for discussion, no specific cut-off points have yet been adopted to define central obesity in Spain. With regard to diabetes, our results suggest optimal cut-offs at 99 cm in men and 90 cm in women. Two other criteria for defining central obesity are available which are mostly used in the diagnosis of metabolic syndrome, those proposed by the IDF for European population (94/80 cm) \[[@B30]\] and those of the NCEP-ATPIII (102/88 cm) \[[@B29]\]. Although less sensitive, the NCEP-ATPIII criterion was much more specific when applied to our cohort; besides, the IDF criterion failed to correctly classify a large proportion of the sample. Until adapted, specific values are defined, our data strongly supports the adoption of NCEP-ATPIII values in the Spanish population to enable international comparability of country data.

Obesity, both general and central, had a greater influence on the risk of T2DM in women than men, consistent with previous evidence \[[@B2]\]. Genetic effects determine sex differences in body composition \[[@B42]\] and hormonal factors \[[@B43]\] have been invoked to account for the weaker association between obesity and T2DM in men. However, reasons for this sex-specific effect are not clear. A gynoid fat pattern, characterised by fat tissue depots in thighs and hip, has been shown to be inversely associated to fasting and postload glucose concentrations, and to diabetes risk, independently of BMI and waist circumference \[[@B44]\]. Larger thigh and hip circumferences in women could reflect increased femoral and gluteal subuctaneous fat mass, which have been reported to show high lipoprotein lipase activity and low lipolytic activity \[[@B44],[@B45]\], thus contributing to fatty acid uptake and storage \[[@B45]\]. In turn, abdominal fat depots are more strongly related to insulin resistance than periferal or gluteal adiposity by releasing larger amounts of free fatty acids into the blood that become lipotoxic for hepatic and muscle cells \[[@B11],[@B46]\]. Thus, women with an android fat pattern (a pattern of central adiposity) might be at higher relative risk of T2DM because of both a diabetogenic effect of intra-abdominal fat and a reduced 'protection' by hip and thigh fat depots, as compared to gynoid females. In support of the latter, Cameron et al. have recently shown the important confounding effect of hip circumference in the association between central obesity and all-cause and cardiovascular mortality, hip circumference being inversely associated to mortality after adjustment by waist circumference \[[@B47]\]. In our study, hip circumference was no longer associated to diabetes risk once weight and waist circumference were accounted for in categorical models, but it showed a significant independent inverse relationship with diabetes in a continuous model (HR~men,\ per\ standard\ deviation~ = 0.90, 95% CI, 0.82 - 0.99; HR~women,\ per\ standard\ deviation~ = 0.73, 95% CI, 0.65 - 0.83; data not shown), which points out to a protective independent effect of hip circumference similar to that suggested by previous authors \[[@B44],[@B47]\]. These results highlight the aetiological role of central obesity in promoting T2DM, but also revive the discussion on the importance of hip circumference as an independent predictor of chronic disease and mortality, especially among women.

The large and increasing prevalence of overweight and obesity, and the ageing of the population in Spain, as in many other countries \[[@B6],[@B7],[@B48]\], raises serious concerns about the future burden of diabetes morbidity and mortality. In our study, we have estimated that around 46% of cases among men, and 61% of cases among women, could be avoided by maintaining a normal weight (BMI \< 25 kg/m^2^). If our relative risk estimates were extrapolated to the general Spanish population, using the most accurate and up-to-date nation-wide figures available for Spain (an overall prevalence of overweight or obesity of 70.8% and 53.9% for men and women respectively \[[@B49]\]), the proportion of diabetes cases that could be avoided if the population kept a normal weight could be calculated in 40.1% (95% CI, 27.3 - 52.9%) in men and 49.7% in women (95% CI, 38.9 - 60.4%). Even further gains are conceivable if lower reductions in BMI or abdominal girth were achieved. However, further extrapolation of these results must be applied with caution, since prevalences and relative risk estimates may vary in other settings.

Some limitations should be considered when interpreting these data. The EPIC-Spain sample was not representative of the general population, consisted of a large proportion of blood donors and included predominantly women, which would limit the generalizability of the results. Furthermore, the prevalence of elevated BMI in this cohort was very high as compared to other populations, particularly those from Asian origin \[[@B50]\], this meaning that the estimated risks (relative and aboslute) and cut-off values obtained should not be directly extrapolated to populations of different geographical, ethnic, or cultural contexts. Unfortunately, no data was available on family history of diabetes, and thus the genetic background of participants could not be accounted for in the analyses. The limited availability of primary care data in one of the study centres might not have resulted in a significant misclassification bias, however, since the associations remained unchanged after excluding the participants from this centre in a sensitivity analysis. Finally, since no additional anthropometric measures were performed during the follow-up, the possibility that participants could have lost or put on weight after recruitment could not be evaluated. Furthermore, it was not possible to assess to what extent potential reductions in weight or WC during the study period would be able to decrease T2DM risk in this population. Important strengths are the large sample size, the prospective design with a long follow-up time, and the use of anthropometric measures, not self-reports. Also, the large number of cases available allowed for robust estimates of T2DM risk across the full range of relevant anthropometric indicators. Finally, a large set of confounders was available to control for, including dietary and lifestyle variables, and mis-reporting of energy intake.

Conclusion
==========

Diabetes risk was consistently associated with higher overall and central obesity indices in adult population, even at BMI and WC values regarded as normal. The study provides specific estimates of diabetes risk (absolute and relative) by categories of anthropometric variables in Spanish men and women, makes the importance of central adiposity indices manifest, especially for women, and promotes the measurement of waist circumference in the clinical setting to assist the evaluation of metabolic risk.
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